Kewaunee Scientific Corporation (NASDAQ:KEQU – Get Free Report) CEO Thomas David Hull III sold 884 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $38.01, for a total transaction of $33,600.84. Following the sale, the chief executive officer owned 35,835 shares of the company’s stock, valued at approximately $1,362,088.35. This represents a 2.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Thomas David Hull III also recently made the following trade(s):
- On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total transaction of $39,000.00.
Kewaunee Scientific Stock Performance
NASDAQ:KEQU opened at $37.41 on Friday. The firm’s fifty day simple moving average is $39.59 and its 200 day simple moving average is $46.85. The company has a current ratio of 2.48, a quick ratio of 1.71 and a debt-to-equity ratio of 0.81. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $71.33. The firm has a market capitalization of $107.37 million, a price-to-earnings ratio of 9.49 and a beta of 0.55.
Analysts Set New Price Targets
KEQU has been the subject of a number of analyst reports. Wall Street Zen cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Saturday, December 13th. Weiss Ratings reissued a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Kewaunee Scientific currently has a consensus rating of “Hold”.
View Our Latest Stock Analysis on Kewaunee Scientific
Institutional Investors Weigh In On Kewaunee Scientific
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Goldman Sachs Group Inc. boosted its stake in shares of Kewaunee Scientific by 125.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock valued at $764,000 after buying an additional 10,803 shares during the last quarter. Punch & Associates Investment Management Inc. acquired a new stake in Kewaunee Scientific in the first quarter valued at $788,000. OMERS ADMINISTRATION Corp acquired a new stake in Kewaunee Scientific in the first quarter valued at $284,000. American Century Companies Inc. boosted its stake in Kewaunee Scientific by 43.4% during the 1st quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock valued at $1,937,000 after acquiring an additional 14,889 shares during the last quarter. Finally, Minerva Advisors LLC grew its holdings in Kewaunee Scientific by 5.0% during the 2nd quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company’s stock worth $4,501,000 after acquiring an additional 3,677 shares in the last quarter. 32.69% of the stock is currently owned by hedge funds and other institutional investors.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.
The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.
See Also
- Five stocks we like better than Kewaunee Scientific
- GOLD ALERT
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Do not delete, read immediately
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
